Alexion Pharmaceuticals is a biopharmaceutical company. Co.'s marketed product, Soliris® (eculizumab), is a therapeutic approved for patients with disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria, a genetic blood disorder; and atypical hemolytic uremic syndrome, a genetic disease. Co.'s clinical programs also include: Asfotase Alfa, a targeted enzyme replacement therapy in clinical trials for patients with Hypophosphatasia; and a pre-Investigational New Drug toxicology study of cyclic Pyranopterin Monophosphate replacement therapy for the treatment of Molybdenum Cofactor Deficiency Disease Type A.

ALXN — Key Stats (updated Friday, May 17, 10:23 AM)

Company Name:  Alexion Pharmaceuticals Inc. Website:  www.alxn.com Sector:  Biotechnology Number of ETFs Holding ALXN:  73 Total Market Value Held by ETFs:  $1,073,872,519 Total Market Capitalization:  $20,531,000,000 % of Market Cap. Held by ETFs:  5.23%

ETFs Holding ALXN

ETF   ALXN Weight   ALXN Amount   IBB   6.10%   $205,343,272           QQQ   0.58%   $202,989,207           SPY   0.14%   $191,877,258           XLV   1.08%   $76,795,667           IVV   0.14%   $59,159,801           IWF   0.24%   $47,597,124           VTI   0.11%   $35,067,071           IWP   0.84%   $31,913,108           IWR   0.39%   $30,252,439           VUG   0.25%   $26,552,473          List of all 73 ETFs holding ALXN »

ALXN — News

Featured Slideshows

10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 25 Top Ranked Socially Responsible Dividend Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 ETFs Crossing Above Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg

Advertising Opportunities on ETF Channel